Paper Details

  1. Home
  2. Paper Details

Inhaled iloprost for therapy in pulmonary arterial hypertension.

Author: BollmannTom, EwertRalf, GläserSven, SchäperChristoph

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article discusses the use of inhalative iloprost for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life, and iloprost is often used in combination with other medications.
Paper Details　
Original Abstract of the Article :
Iloprost (Ventavis, Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the admin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1586/ers.11.14

データ提供：米国国立医学図書館（NLM）

Inhaled Iloprost for Pulmonary Arterial Hypertension: A Breath of Fresh Air

Pulmonary arterial hypertension (PAH) is a debilitating condition that affects the arteries in the lungs. The search for effective treatments that improve quality of life for PAH patients is an ongoing endeavor. This study focuses on inhaled iloprost, a synthetic prostacyclin that has emerged as a promising therapeutic option.

The authors highlight the benefits of inhaled iloprost therapy, including improved exercise capacity and quality of life. The use of specialized nebulizers ensures accurate delivery of the medication to the lungs, minimizing side effects. Inhaled iloprost can be safely and effectively combined with other PAH medications, providing a comprehensive approach to managing this complex condition.

A Targeted and Safe Approach to PAH Treatment

The study underscores the importance of targeted therapy in PAH, highlighting the benefits of inhaled iloprost as a safe and effective treatment option. The use of specialized nebulizers ensures accurate delivery of the medication to the lungs, maximizing its effectiveness and minimizing potential side effects.

Hope for PAH Patients: Improved Quality of Life

The study offers hope for PAH patients by demonstrating the potential of inhaled iloprost to improve exercise capacity and quality of life. This targeted therapy provides a valuable tool for managing PAH, enabling patients to live more active and fulfilling lives.

Dr.Camel's Conclusion

This study provides valuable insights into the potential of inhaled iloprost as a therapeutic option for PAH. The targeted delivery and effectiveness of this medication offer a beacon of hope for patients seeking to improve their quality of life and regain control over their health.

Date :
  1. Date Completed 2011-08-16
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

21510725

DOI: Digital Object Identifier

10.1586/ers.11.14

Related Literature

Article Analysis
・Side Effects of iloprost
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.